Home Newsfeeds Eliem Therapeutics Q2 EPS $(0.56) Up From $(3.11) YoY

Eliem Therapeutics Q2 EPS $(0.56) Up From $(3.11) YoY

Eliem Therapeutics (NASDAQ:ELYM) reported quarterly losses of $(0.56) per share. This is a 81.99 percent increase over losses of $(3.11) per share from the same period last year.

byBenzinga Newsdesk

August 15, 2022

1 minute read

Eliem Therapeutics (NASDAQ:ELYM) reported quarterly losses of $(0.56) per share. This is a 81.99 percent increase over losses of $(3.11) per share from the same period last year.

News

Chevron Invests in Carbon Capture And Removal Technology Company, ION Clean Energy; ION Raised $45M In Series A Financing Led By CNE

By Benzinga Newsdesk

April 4, 9:03 AM

Chevron New Energies (CNE), a division of Chevron U.S.A. Inc., announced a lead investment in ION Clean Energy (ION), a Boulder-based technology company that provides post-combustion point-source capture technology

CVX

News

Infosys Collaborates with Musgrave to Drive Cognitive First IT Transformation

By Benzinga Newsdesk

January 31, 6:29 AM

Infosys (NSE: INFY), (BSE: INFY), (NYSE:INFY), a global leader in next-generation digital services and consulting, today announced that it has signed a seven-year strategic collaboration

INFY

VOXX International Q1 EPS $(0.27) May Not Compare To $0.11 Estimate, Sales $128.70M Miss $134.03M Estimate

By Bill Haddad

July 11, 4:06 PM

VOXX International (NASDAQ:VOXX) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $0.11 by 345.45 percent. This is a 268.75 percent decrease over earnings of $0.16 per share

VOXX